Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$5.88−0.75 (-11.31%)
Close on Nov 13, 2026Market cap $88.10MP/E 1.3Yield –
Cumberland Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cumberland Pharmaceuticals's pe ratio was 242.5× on Jul 29, 2016, against 51.9× a year earlier. Over the last 5 years it ranged from 14.6× to 299.0×, with a median of 40.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Jul 29, 2016 | 242.5× | +167.4 |
| 2015 | Dec 31, 2015 | 75.1× | −223.9 |
| 2014 | Dec 31, 2014 | 299.0× | +226.0 |
| 2013 | Dec 31, 2013 | 73.0× | +56.2 |
| 2012 | Dec 31, 2012 | 16.8× | −3.1 |
| 2011 | Dec 30, 2011 | 19.9× | −15.3 |
| 2010 | Dec 31, 2010 | 35.2× | – |
See a number that looks wrong?